Participating Providence patients and their doctors will learn about their risks, if any, for certain inherited diseases that have clear recommendations for prevention and treatment. These inherited diseases include certain cancers, such as breast and prostate cancer, as well as inherited heart diseases. Participants with an increased genetic risk for these diseases will have the opportunity to meet with a genetic counselor to review their results. With the genetic counselor, they will discuss a personal action plan based on national risk management guidelines, including additional screening recommendations or prevention strategies.
Providence participants and their doctors will also learn if they are likely to respond differently to certain medications because of their genetics. Pharmacogenomics, the study of how genes may affect the way medications work, can help doctors choose drugs and dosages that maximize benefits and minimize side effects for participants based on their genetic data. The genomic screen will look for known factors that could predict or explain responses to several commonly prescribed medications, including several antidepressants, acid-reducing medications, and blood thinners.
There is no cost for participating in this study.